OP9 Bone Marrow Stroma Cells Differentiate into Megakaryocytes and Platelets

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Mar 8

PMID 23469264

Citations 11

Authors

Yumiko Matsubara

Yukako Ono

Hidenori Suzuki

Fumio Arai

Toshio Suda

Mitsuru Murata

Yasuo Ikeda

Affiliations

Soon will be listed here.

Abstract

Platelets are essential for hemostatic plug formation and thrombosis. The mechanisms of megakaryocyte (MK) differentiation and subsequent platelet production from stem cells remain only partially understood. The manufacture of megakaryocytes (MKs) and platelets from cell sources including hematopoietic stem cells and pluripotent stem cells have been highlighted for studying the platelet production mechanisms as well as for the development of new strategies for platelet transfusion. The mouse bone marrow stroma cell line OP9 has been widely used as feeder cells for the differentiation of stem cells into MK lineages. OP9 cells are reported to be pre-adipocytes. We previously reported that 3T3-L1 pre-adipocytes differentiated into MKs and platelets. In the present study, we examined whether OP9 cells differentiate into MKs and platelets using MK lineage induction (MKLI) medium previously established to generate MKs and platelets from hematopoietic stem cells, embryonic stem cells, and pre-adipocytes. OP9 cells cultured in MKLI medium had megakaryocytic features, i.e., positivity for surface markers CD41 and CD42b, polyploidy, and distinct morphology. The OP9-derived platelets had functional characteristics, providing the first evidence for the differentiation of OP9 cells into MKs and platelets. We then analyzed gene expressions of critical factors that regulate megakaryopoiesis and thrombopoiesis. The gene expressions of p45NF-E2, FOG, Fli1, GATA2, RUNX1, thrombopoietin, and c-mpl were observed during the MK differentiation. Among the observed transcription factors of MK lineages, p45NF-E2 expression was increased during differentiation. We further studied MK and platelet generation using p45NF-E2-overexpressing OP9 cells. OP9 cells transfected with p45NF-E2 had enhanced production of MKs and platelets. Our findings revealed that OP9 cells differentiated into MKs and platelets in vitro. OP9 cells have critical factors for megakaryopoiesis and thrombopoiesis, which might be involved in a mechanism of this differentiation. p45NF-E2 might also play important roles in the differentiation of OP9 cells into MK lineages cells.

Citing Articles

NLRP3 inflammasome inhibition of OP9 cells enhance therapy for inflammatory bowel disease.

Chen Y, Meng W, Ren G, An N, Zhang J, Liu Z Heliyon. 2023; 9(7):e18038.

PMID: 37483815 PMC: 10362138. DOI: 10.1016/j.heliyon.2023.e18038.

Single-Cell RNA-Seq Reveals LRRC75A-Expressing Cell Population Involved in VEGF Secretion of Multipotent Mesenchymal Stromal/Stem Cells Under Ischemia.

Miura T, Kouno T, Takano M, Kuroda T, Yamamoto Y, Kusakawa S Stem Cells Transl Med. 2023; 12(6):379-390.

PMID: 37263619 PMC: 10267575. DOI: 10.1093/stcltm/szad029.

Generation of HLA Universal Megakaryocytes and Platelets by Genetic Engineering.

Figueiredo C, Blasczyk R Front Immunol. 2021; 12:768458.

PMID: 34777386 PMC: 8579098. DOI: 10.3389/fimmu.2021.768458.

Platelet production using adipose-derived mesenchymal stem cells: Mechanistic studies and clinical application.

Ono-Uruga Y, Ikeda Y, Matsubara Y J Thromb Haemost. 2020; 19(2):342-350.

PMID: 33217130 PMC: 7898515. DOI: 10.1111/jth.15181.

Developments in the production of platelets from stem cells (Review).

Yang J, Luan J, Shen Y, Chen B Mol Med Rep. 2020; 23(1).

PMID: 33179095 PMC: 7673345. DOI: 10.3892/mmr.2020.11645.

References

Deutsch V, Tomer A . Megakaryocyte development and platelet production. Br J Haematol. 2006; 134(5):453-66. DOI: 10.1111/j.1365-2141.2006.06215.x. View

Gaur M, Kamata T, Wang S, Moran B, Shattil S, Leavitt A . Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. J Thromb Haemost. 2006; 4(2):436-42. DOI: 10.1111/j.1538-7836.2006.01744.x. View

Pang L, Weiss M, Poncz M . Megakaryocyte biology and related disorders. J Clin Invest. 2005; 115(12):3332-8. PMC: 1297258. DOI: 10.1172/JCI26720. View

Colman A, Dreesen O . Induced pluripotent stem cells and the stability of the differentiated state. EMBO Rep. 2009; 10(7):714-21. PMC: 2727431. DOI: 10.1038/embor.2009.142. View

Fock E, Yan F, Pan S, Chong B . NF-E2-mediated enhancement of megakaryocytic differentiation and platelet production in vitro and in vivo. Exp Hematol. 2007; 36(1):78-92. DOI: 10.1016/j.exphem.2007.08.015. View

Matsubara Y, Murata M, Ikeda Y . Culture of megakaryocytes and platelets from subcutaneous adipose tissue and a preadipocyte cell line. Methods Mol Biol. 2011; 788:249-58. DOI: 10.1007/978-1-61779-307-3_17. View

Nakano T, Kodama H, Honjo T . Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science. 1994; 265(5175):1098-101. DOI: 10.1126/science.8066449. View

Kerrigan S, Gaur M, Murphy R, Shattil S, Leavitt A . Caspase-12: a developmental link between G-protein-coupled receptors and integrin alphaIIbbeta3 activation. Blood. 2004; 104(5):1327-34. DOI: 10.1182/blood-2003-10-3633. View

Fuentes R, Wang Y, Hirsch J, Wang C, Rauova L, Worthen G . Infusion of mature megakaryocytes into mice yields functional platelets. J Clin Invest. 2010; 120(11):3917-22. PMC: 2964983. DOI: 10.1172/JCI43326. View

10.

Takayama N, Nishikii H, Usui J, Tsukui H, Sawaguchi A, Hiroyama T . Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood. 2008; 111(11):5298-306. DOI: 10.1182/blood-2007-10-117622. View

11.

Andrews N, Erdjument-Bromage H, Davidson M, Tempst P, Orkin S . Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature. 1993; 362(6422):722-8. DOI: 10.1038/362722a0. View

12.

Mignotte V, Wall L, DEBOER E, Grosveld F, Romeo P . Two tissue-specific factors bind the erythroid promoter of the human porphobilinogen deaminase gene. Nucleic Acids Res. 1989; 17(1):37-54. PMC: 331534. DOI: 10.1093/nar/17.1.37. View

13.

Vicente C, Conchillo A, Garcia-Sanchez M, Odero M . The role of the GATA2 transcription factor in normal and malignant hematopoiesis. Crit Rev Oncol Hematol. 2011; 82(1):1-17. DOI: 10.1016/j.critrevonc.2011.04.007. View

14.

Clemetson K . Platelets and primary haemostasis. Thromb Res. 2011; 129(3):220-4. DOI: 10.1016/j.thromres.2011.11.036. View

15.

Peters L, Andrews N, Eicher E, Davidson M, Orkin S, Lux S . Mouse microcytic anaemia caused by a defect in the gene encoding the globin enhancer-binding protein NF-E2. Nature. 1993; 362(6422):768-70. DOI: 10.1038/362768a0. View

16.

Shivdasani R, Rosenblatt M, Zucker-Franklin D, Jackson C, Hunt P, Saris C . Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell. 1995; 81(5):695-704. DOI: 10.1016/0092-8674(95)90531-6. View

17.

Chang Y, Bluteau D, Debili N, Vainchenker W . From hematopoietic stem cells to platelets. J Thromb Haemost. 2007; 5 Suppl 1:318-27. DOI: 10.1111/j.1538-7836.2007.02472.x. View

18.

Andrews N . The NF-E2 transcription factor. Int J Biochem Cell Biol. 1998; 30(4):429-32. DOI: 10.1016/s1357-2725(97)00135-0. View

19.

Kaushansky K . Historical review: megakaryopoiesis and thrombopoiesis. Blood. 2008; 111(3):981-6. PMC: 2214745. DOI: 10.1182/blood-2007-05-088500. View

20.

Eto K, Murphy R, Kerrigan S, Bertoni A, Stuhlmann H, Nakano T . Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling. Proc Natl Acad Sci U S A. 2002; 99(20):12819-24. PMC: 130543. DOI: 10.1073/pnas.202380099. View